| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 37,898 | 31,855 | 23,059 | 34,417 | | Cost of Revenue | 9,277 | 13,356 | 13,355 | 15,235 | | | Gross Profit | 28,621 | 18,499 | 9,704 | 19,182 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,492 | 3,900 | 3,368 | 2,524 | | Non Recurring | 2,135 | 483 | 1,364 | 76,706 | | Others | 13,302 | 13,549 | 16,621 | 30,101 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,427 | 567 | (11,649) | (90,149) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,189 | (59,160) | 19,510 | 231,971 | | Earnings Before Interest And Taxes | 7,897 | (58,594) | 7,859 | 141,795 | | Interest Expense | 8,612 | (1,761) | 4,259 | 13,989 | | Income Before Tax | (715) | (56,833) | 3,600 | 127,806 | | Income Tax Expense | 136 | 159 | 111 | (580) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (851) | (56,992) | 3,489 | 128,386 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (1,250) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (851) | (56,992) | 3,489 | 127,136 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($851) | ($56,992) | $3,489 | $127,136 |
|
0.02% Nasdaq 0.00%
Income Statement
